HomeTagsA.forall

A.forall

Biotechnology

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

News Desk - July 26, 2024

A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL...

Hot Topics

Tredence Launches Supply Chain Command Center on Snowflake AI Cloud

Amazon Backs X-energy for Advanced Small Nuclear Reactors, Boosts Carbon-Free Power

John Bell Named CTO of HII’s Mission Technologies Division